Literature DB >> 33899493

Interplay Between Reactive Oxygen/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease.

Masuko Ushio-Fukai1,2, Dipankar Ash1,2, Sheela Nagarkoti1,2, Eric J Belin de Chantemèle1,2, David J R Fulton1,3, Tohru Fukai1,3,4.   

Abstract

Reactive oxygen species (ROS; e.g., superoxide [O2•-] and hydrogen peroxide [H2O2]) and reactive nitrogen species (RNS; e.g., nitric oxide [NO•]) at the physiological level function as signaling molecules that mediate many biological responses, including cell proliferation, migration, differentiation, and gene expression. By contrast, excess ROS/RNS, a consequence of dysregulated redox homeostasis, is a hallmark of cardiovascular disease. Accumulating evidence suggests that both ROS and RNS regulate various metabolic pathways and enzymes. Recent studies indicate that cells have mechanisms that fine-tune ROS/RNS levels by tight regulation of metabolic pathways, such as glycolysis and oxidative phosphorylation. The ROS/RNS-mediated inhibition of glycolytic pathways promotes metabolic reprogramming away from glycolytic flux toward the oxidative pentose phosphate pathway to generate nicotinamide adenine dinucleotide phosphate (NADPH) for antioxidant defense. This review summarizes our current knowledge of the mechanisms by which ROS/RNS regulate metabolic enzymes and cellular metabolism and how cellular metabolism influences redox homeostasis and the pathogenesis of disease. A full understanding of these mechanisms will be important for the development of new therapeutic strategies to treat diseases associated with dysregulated redox homeostasis and metabolism. Antioxid. Redox Signal. 34, 1319-1354.

Entities:  

Keywords:  metabolism; oxidative stress; reactive nitrogen species; reactive oxygen species; redox signaling

Mesh:

Substances:

Year:  2021        PMID: 33899493      PMCID: PMC8418449          DOI: 10.1089/ars.2020.8161

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   7.468


  400 in total

1.  Disruption of fusion results in mitochondrial heterogeneity and dysfunction.

Authors:  Hsiuchen Chen; Anne Chomyn; David C Chan
Journal:  J Biol Chem       Date:  2005-05-17       Impact factor: 5.157

2.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

Authors:  Jiangbin Ye; Anthony Mancuso; Xuemei Tong; Patrick S Ward; Jing Fan; Joshua D Rabinowitz; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 3.  The role of AMPK in T cell metabolism and function.

Authors:  Eric H Ma; Maya C Poffenberger; Alison H-T Wong; Russell G Jones
Journal:  Curr Opin Immunol       Date:  2017-04-28       Impact factor: 7.486

4.  Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.

Authors:  Lisa S Pike; Amy L Smift; Nicole J Croteau; David A Ferrick; Min Wu
Journal:  Biochim Biophys Acta       Date:  2011-06

5.  Inhibition of mitochondrial electron transport by peroxynitrite.

Authors:  R Radi; M Rodriguez; L Castro; R Telleri
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

Review 6.  Emerging Moonlighting Functions of the Branched-Chain Aminotransferase Proteins.

Authors:  Myra Elizabeth Conway
Journal:  Antioxid Redox Signal       Date:  2020-08-03       Impact factor: 8.401

7.  A pivotal role for tryptophan 447 in enzymatic coupling of human endothelial nitric oxide synthase (eNOS): effects on tetrahydrobiopterin-dependent catalysis and eNOS dimerization.

Authors:  Matthew A Benson; Helen Batchelor; Surawee Chuaiphichai; Jade Bailey; Hanneng Zhu; Dennis J Stuehr; Shoumo Bhattacharya; Keith M Channon; Mark J Crabtree
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

8.  Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells.

Authors:  Oliver A Stone; Mohamed El-Brolosy; Kerstin Wilhelm; Xiaojing Liu; Ana M Romão; Elisabetta Grillo; Jason K H Lai; Stefan Günther; Sylvia Jeratsch; Carsten Kuenne; I-Ching Lee; Thomas Braun; Massimo M Santoro; Jason W Locasale; Michael Potente; Didier Y R Stainier
Journal:  Nat Commun       Date:  2018-10-09       Impact factor: 14.919

9.  CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin.

Authors:  Ikjun Lee; Seonhee Kim; Harsha Nagar; Su-Jeong Choi; Byeong Hwa Jeon; Shuyu Piao; Cuk-Seong Kim
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

Review 10.  Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.

Authors:  Bozidarka L Zaric; Jelena N Radovanovic; Zoran Gluvic; Alan J Stewart; Magbubah Essack; Olaa Motwalli; Takashi Gojobori; Esma R Isenovic
Journal:  Front Immunol       Date:  2020-09-28       Impact factor: 7.561

View more
  7 in total

Review 1.  Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.

Authors:  Getinet M Adinew; Equar Taka; Bereket Mochona; Ramesh B Badisa; Elizabeth A Mazzio; Rashid Elhag; Karam F A Soliman
Journal:  Nutrients       Date:  2021-12-25       Impact factor: 5.717

2.  Study on the Effects of Chinese Materia Medica Processing on the Hypoglycemic Activity and Chemical Composition of Anemarrhenae Rhizoma.

Authors:  Ying-Qi Yu; Li Yan; Xiao-Ting Wang; Li Li; Wei Zheng; Hui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

Review 3.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

4.  Modeling oxidative injury response in human kidney organoids.

Authors:  Aneta Przepiorski; Thitinee Vanichapol; Eugenel B Espiritu; Amanda E Crunk; Emily Parasky; Michael D McDaniels; Dave R Emlet; Ryan Salisbury; Cassandra L Happ; Lawrence A Vernetti; Matthew L MacDonald; John A Kellum; Thomas R Kleyman; Catherine J Baty; Alan J Davidson; Neil A Hukriede
Journal:  Stem Cell Res Ther       Date:  2022-02-21       Impact factor: 6.832

5.  Editorial: Mitochondria, metabolism and cardiovascular diseases.

Authors:  Jun-Ichiro Koga; Xinghui Sun; Masuko Ushio-Fukai
Journal:  Front Cardiovasc Med       Date:  2022-08-19

6.  Coupling of phagocytic NADPH oxidase activity and mitochondrial superoxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Igor A Kirilyuk
Journal:  Front Cardiovasc Med       Date:  2022-07-28

7.  Alpha-ketoglutarate ameliorates abdominal aortic aneurysm via inhibiting PXDN/HOCL/ERK signaling pathways.

Authors:  Junjun Liu; Mingyuan Liu; Jiaxuan Feng; Hongqiao Zhu; Jianlie Wu; Heng Zhang; Shun Xiao; Zaiping Jing; Jian Zhou; Haitao Niu; Mingjin Guo
Journal:  J Transl Med       Date:  2022-10-08       Impact factor: 8.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.